News – OxSonics

OxSonics Signs Evaluation Agreement with Large Pharma Company

9th December 2020/in News /by Ruth Barrett

Nicholas Adams Joins OxSonics as Chief Business Officer

10th August 2020/in News /by Ruth Barrett

OxSonics Raises £10.5m in Oversubscribed Series B2 Equity Financing

3rd July 2020/in News /by Ruth Barrett

OxSonics Wins The Gold Award at the 2019 Tech Tour Contest Grand Final

10th December 2019/in News /by Nikolaos

OxSonics CEO Interview At BIO Investor Forum San Francisco

23rd October 2019/in News /by Nikolaos

SonoTran® Particles Patent Granted in the United States and Japan

15th October 2019/in News /by Nikolaos

OxSonics Co-Founder & CSO Professor Constantin Coussios elected as a Fellow of the Royal Academy of Engineering

30th September 2019/in News /by Nikolaos

OxSonics® Wins European Healthtech Investment Forum Competition

13th March 2019/in News /by Nikolaos

OxSonics’ CEO Interview At BIO CEO Investor Conference

11th February 2019/in News /by Nikolaos

OxSonics Launches New Website & Renames as OxSonics Therapeutics

7th January 2019/in News /by hedgehog

Oxford, UK – 7th January 2019 – OxSonics, a world leader in the development of ultrasound-based drug delivery systems for the treatment of cancer today announced the launch of its new website and its new name “OxSonics Therapeutics”. Colin Story, CEO, commented: “OxSonics Therapeutics innovative drug delivery platform is designed to deliver significant therapeutic advantages to those […]